Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.1 USD | +0.40% | -1.33% | -1.42% |
Apr. 17 | Declaration of Voting Results by IQVIA Holdings | CI |
Apr. 10 | Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US | MT |
Evolution of the average Target Price on Iqvia Holdings Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Iqvia Holdings Inc.
Truist Securities | |
Leerink Partners | |
Deutsche Bank Securities | |
UBS | |
Barclays | |
Baird | |
Guggenheim | |
BTIG | |
Citigroup | |
JPMorgan Chase | |
Mizuho Securities | |
HSBC | |
Stifel Nicolaus | |
Morgan Stanley | |
Wells Fargo Securities | |
Cowen | |
Credit Suisse | |
Evercore ISI | |
Jefferies & Co. | |
Argus | |
SVB Securities LLC | |
Piper Sandler | |
KeyBanc Capital Markets | |
BofA Securities | |
Stephens Inc. |
EPS Revisions
- Stock Market
- Equities
- IQV Stock
- Consensus Iqvia Holdings Inc.